KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt issuances
Ratios

Idexx Laboratories (IDXX) Long-Term Debt Issuances: 2009-2022

Historic Long-Term Debt Issuances for Idexx Laboratories (IDXX) over the last 9 years, with Dec 2022 value amounting to -$559.5 million.

  • Idexx Laboratories' Long-Term Debt Issuances was N/A to -$559.5 million in Q4 2022 from the same period last year, while for Sep 2022 it was $561.4 million, marking a year-over-year change of. This contributed to the annual value of $200.0 million for FY2020, which is 100.00% up from last year.
  • According to the latest figures from Q4 2022, Idexx Laboratories' Long-Term Debt Issuances is -$559.5 million, which was down 200.00% from $559.5 million recorded in Q3 2022.
  • Idexx Laboratories' 5-year Long-Term Debt Issuances high stood at $559.5 million for Q3 2022, and its period low was -$559.5 million during Q4 2022.
  • For the 2-year period, Idexx Laboratories' Long-Term Debt Issuances averaged around $33.3 million, with its median value being $100.0 million (2020).
  • Examining YoY changes over the last 5 years, Idexx Laboratories' Long-Term Debt Issuances showed a top increase of 869.60% in 2018 and a maximum decrease of 512.50% in 2018.
  • Quarterly analysis of 4 years shows Idexx Laboratories' Long-Term Debt Issuances stood at $240.5 million in 2018, then spiked by 140.40% to $100.0 million in 2019, then spiked by 98.11% to $1.9 million in 2020, then reached -$559.5 million in 2022.
  • Its Long-Term Debt Issuances was -$559.5 million in Q4 2022, compared to $559.5 million in Q3 2022 and -$326.5 million in Q2 2022.